QUANTGENE

Ending Cancer with Intelligent Genomics

https://wefunder.com/quantgene

Total raised on Wefunder: 0

Total investors: 0

Quick facts

  • Realized $50mm in revenue.
  • Combines genomics, AI and medical intelligence technology for universal cancer detection.
  • Pole position to disrupt the $168B cancer diagnostics and early detection market.
  • Invested $36mm into R&D to date.
  • $200mm current deal pipeline with hospital systems.
  • Established distribution partnerships to reach 70,000 customers in 2024 for its Qx solution.

Team profiles

Featured investor profiles

QUANTGENE

Ending Cancer with Intelligent Genomics

EARLY BIRD TERMS: $96,750 LEFT

$3,250

of a $50,000 goal
INVESTMENT TERMS
Future Equity
 $80M  $60M valuation cap
Early Bird Bonus: The first $100K of investments will be in a SAFE with a $60M valuation cap
$1K, $2K, $5K, $25K
Posts